Computationally predicting clinical drug combination efficacy with cancer cell line screens and independent drug action
Computational models that can predict drug combination efficacy are often based on drug synergy. Here, the authors develop a different approach to computationally predict the efficacy of drug combinations using monotherapy data from high-throughput cancer cell line screens.
Saved in:
Main Authors: | Alexander Ling, R. Stephanie Huang |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/d1fa96cd03394bc89c33eaee9b5d9687 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
by: Michael P. Menden, et al.
Published: (2019) -
Generation of a predictive melphalan resistance index by drug screen of B-cell cancer cell lines.
by: Martin Boegsted, et al.
Published: (2011) -
Network-based in silico drug efficacy screening
by: Emre Guney, et al.
Published: (2016) -
Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs
by: Henry Gerdes, et al.
Published: (2021) -
Network-based prediction of drug combinations
by: Feixiong Cheng, et al.
Published: (2019)